Tecentriq 840mg Injection

Price 2091.0 USD ($)/ Piece

Get a Price/Quote

MOQ : 1 Piece

Tecentriq 840mg Injection Specification

Indication
Indicated for the treatment of certain types of cancer, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), urothelial carcinoma, triple-negative breast cancer, and hepatocellular carcinoma

Salt Composition
Atezolizumab 840mg

Dosage Form
Injection

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level

Temperature Needed For Fermentation
Not applicable Fahrenheit (oF)

Physical Color/Texture
Other

Fermentation Smell

Enzymatic Activity
Not applicable (acts by immune checkpoint inhibition)

Storage Instructions
Store refrigerated at 2C to 8C. Do not freeze. Protect from light.

Shelf Life
18 months Months

Marketed By
Roche Products (India) Pvt. Ltd.

Use in Pediatrics
Safety and efficacy not established in pediatric patients

Route of Administration
Intravenous infusion only

Container Type
Single-dose vial

ATC Code
L01XC32

Prescription Status
Prescription-only medication

Contraindications
Hypersensitivity to atezolizumab or any excipient

Packaging Size
1 vial of 14 mL (840mg/14ml)

About Tecentriq 840mg Injection

Tecentriq 840mg Injection, lauded for its favorable reviews and cost-effective profile, is a valiant and noble choice in advanced cancer immunotherapy. Formulated as a humanized monoclonal antibody, this magnificent intravenous treatment targets immune checkpoints, helping the body fight several serious cancers, including NSCLC, SCLC, urothelial carcinoma, triple-negative breast cancer, and hepatocellular carcinoma. Packaged in a single-dose vial and ready-to-use, it is prescription-only and expertly crafted by Roche Products (India) Pvt. Ltd. Shop now to access a premium solution trusted by healthcare professionals across India.

Tecentriq 840mg Injection: Advantage and Suitable Use

Tecentriq 840mg Injection offers a substantial advantage in oncological care as an immune checkpoint inhibitor used for the treatment of multiple types of cancer. Its formulation is suitable for adults diagnosed with NSCLC, SCLC, urothelial carcinoma, triple-negative breast cancer, and hepatocellular carcinoma. As a prescription-only medication, Tecentriq delivers precise, reliable results for eligible patients. It stands out for its ready-to-use design and advanced immunotherapy approach that targets malignant cells effectively.

Premium Packaging & Supply Capabilities of Tecentriq 840mg Injection

Tecentriq 840mg Injection comes in a premium single-dose vial containing 14 mL of clear-to-pale yellow solution. Exporters, suppliers, traders, and wholesalers in India can benefit from a consistent supply and favorable sample policy to ensure accessibility at the lowest price possible. Packaged for utmost safety and maintained under optimal refrigerated conditions, each vial ensures product integrity from distribution to administration. Sample requests and bulk orders are supported with responsive supply chains to meet clinical demands.

FAQ's of Tecentriq 840mg Injection:

Q: How is Tecentriq 840mg Injection administered to patients?

A: Tecentriq 840mg Injection is administered as an intravenous infusion by a healthcare professional in a clinical setting under strict medical supervision.

Q: What types of cancers can Tecentriq 840mg Injection treat?

A: Tecentriq is indicated for the treatment of non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), urothelial carcinoma, triple-negative breast cancer, and hepatocellular carcinoma.

Q: When is Tecentriq 840mg Injection not recommended?

A: Tecentriq should not be used in patients with known hypersensitivity to atezolizumab or any of its excipients. Its safety and efficacy are not established for pediatric patients.

Q: What storage conditions are required for Tecentriq 840mg Injection?

A: Tecentriq 840mg Injection must be stored refrigerated at 2C to 8C, protected from light, and must not be frozen to maintain its integrity.

Q: What are the primary advantages of Tecentriq 840mg Injection?

A: Tecentriq's primary advantages include its immune checkpoint inhibition mechanism, ready-to-use formulation, and favorable cost-effectiveness for eligible adult cancer patients.

Tell us about your requirement